Gilead Sciences Inc (GILD)
Financial leverage ratio
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | US$ in thousands | 62,125,000 | 62,373,000 | 62,337,000 | 61,876,000 | 63,171,000 | 62,557,000 | 62,870,000 | 63,080,000 | 67,952,000 | 67,098,000 | 67,984,000 | 67,492,000 | 68,407,000 | 60,878,000 | 55,934,000 | 59,741,000 | 61,627,000 | 59,146,000 | 63,210,000 | 62,837,000 |
| Total stockholders’ equity | US$ in thousands | 22,833,000 | 22,314,000 | 21,158,000 | 20,997,000 | 21,240,000 | 21,081,000 | 20,236,000 | 19,927,000 | 21,069,000 | 21,470,000 | 19,703,000 | 18,952,000 | 18,202,000 | 17,445,000 | 18,027,000 | 22,067,000 | 22,525,000 | 20,604,000 | 22,616,000 | 21,951,000 |
| Financial leverage ratio | 2.72 | 2.80 | 2.95 | 2.95 | 2.97 | 2.97 | 3.11 | 3.17 | 3.23 | 3.13 | 3.45 | 3.56 | 3.76 | 3.49 | 3.10 | 2.71 | 2.74 | 2.87 | 2.79 | 2.86 |
December 31, 2023 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $62,125,000K ÷ $22,833,000K
= 2.72
Gilead Sciences, Inc.'s financial leverage ratio has shown a fluctuating trend over the past eight quarters. The ratio decreased from 2.97 in Q4 2022 to 2.72 in Q4 2023, suggesting a reduction in the company's reliance on debt to finance its operations. However, this was followed by an increase in Q1 2023 to 2.95, where it remained stable in Q2 2023 before increasing again in Q3 2023 to 2.80.
The financial leverage ratio peaked in Q1 2022 at 3.17 and has since shown a gradual decline. This indicates a potential improvement in the company's financial stability and ability to meet its financial obligations, as lower financial leverage ratios imply a lower proportion of debt in the company's capital structure.
Overall, the fluctuations in Gilead Sciences, Inc.'s financial leverage ratio suggest varying levels of debt usage over the quarters, with recent trends indicating a potential shift towards a more conservative capital structure. It is important for investors and stakeholders to continue monitoring these ratios to assess the company's risk profile and financial health.
Peer comparison
Dec 31, 2023